The effect of an endothelin antagonist on blood pressure in a rat model of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 3, 1999, Pages 638-641

  Olson, Gayle L ^a,c   Saade, George R ^a   Buhimschi, Irina ^a   Chwalisz, Kristof ^b   Garfield, Robert E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Endothelin; Nitric oxide inhibition; Preeclampsia

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; PREECLAMPSIA; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032876291     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70506-5     Document Type: Article

References (25)

1. 1. Buhimschi I, Yallampalli C, Chwalisz K, Garfield RE. Preeclampsia-like conditions produced by nitric oxide inhibition: effects of L-arginine, D-arginine and steroid hormones. Hum Reprod 1995;10:2723-30.
2. 2. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316-20.
3. 3. Molnár M, Sütö T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994;170:1458-66.
4. 4. Baylis C, Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial derived relaxing factor (EDRF) in the rat. Clin Exp Hypertens 1992;B11:117-29.
5. ω-Nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992;166:1560-7.
6. 6. Zeeman GG, Dekker GA. Pathogenesis of preeclampsia: a hypothesis. Clin Obstet Gynecol 1992;35:317-37.
7. 7. Edwards DL, Arora CP, Bui DT, Castro LC. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. Am J Obstet Gynecol 1996;175:484-8.
8. 8. Noll G, Wenzel RR, Luscher TF. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease. Mol Cell Biochem 1996;157:259-67.
9. 9. Ehrenreich H, Schilling L. New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleve Clin J Med 1995;62:105-16.
10. 10. Leszczynska-Gorzelak B, Kaminski K, Szymula D, Sawulicka-Oleszczuk H, Oleszczuk J. Serum level of endothelin-1 and -2 in pregnancies complicated by EPH gestosis. Gynecol Obstet Invest 1997;43:37-40.
11. 11. Halim A, Kanayama N, Machara K, Takahashi M, Terao T, HELLP syndrome-like biochemical parameters obtained with endothelin-1 injections in rabbits. Gynecol Obstet Invest 1993;35:193-8.
12. 12. Halim A, Kanayama N, Maraduy E, Maehara K, Shimoyama I, Sumimot K, et al. Eclampsia-like seizures and electroencephalographic changes in pregnant rabbits with endothelin-1 injections. Gynecol Obstet Invest 1995;39:1-7.
13. 13. Cockell AP, Poston L. Flow mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997;30:247-51.
14. 14. Veille JC, Gorsuch L, Weeks W, Zaccaro D. Hyperemic response of the brachial artery during the second half of pregnancy. J Soc Gynecol Invest 1998;5:38-43.
15. 15. Ashworth JR, Warren AY, Baker PN, Johnson IR. Loss of endothelium-dependent relaxation in myometrial resistance arteries in preeclampsia. Br J Obstet Gynaecol 1997;104:1152-8.
16. 16. Knock GA, Poston L. Bradykinin-mediated relaxation of isolated maternal resistance arteries in normal pregnancy and preeclampsia. Am J Obstet Gynecol 1996;175:1668-74.
17. 17. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 1993;21:294-300.
18. 18. Larivière R, Sventek P, Schiffrin EL. Expression of endothelin-1 gene in blood vessels of spontaneously hypertensive rats. Life Sci 1995;56:1889-96.
19. 19. Filep JG. Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension 1997;30:22-8.
20. 20. Halim A, Kanayama N, El Maradny E, Maehara K, Toshihiko T. Coagulation in vivo microcirculation and in vitro caused by endothelin-1. Thromb Res 1993;72:203-9.
21. 21. Wolff K, Nisell H, Carlstrom K, Kublickiene K, Hemsen A, Lunell NO, et al. Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept 1996;67:211-6.
22. 22. Maguire JJ, Kuc RE, Rous BA, Davenport AP. Faulure of BQ123, a more potent antagonist of sarafotoxin 6b tan of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol 1996;118:335-42.
23. 23. Wight E, Küng CF, Moreau P, Takase H, Lüscher TF. Chronic blockade of nitric oxide-synthase and endothelin receptors during pregnancy in the rat: effect on pregnancy outcome. J Soc Gynecol Invest 1998;5:132-9.
24. 24. Mondon F, Doualla-Bell F, Maka K, Sabry S, Ferré F. Endothelin-induced phosphoinositide hydrolysis in the muscular layer of stem villi vessels of human term placenta. Eur J Endocrinol 1995;133:606-12.
25. 25. Heluy V, Breuiller-Fouche M, Cavaille F, Fournier T, Ferre F. Characterization of type A endothelin receptors in cultured human myometrial cells. Am J Physiol 1995;268:E825-31.